|
Published by: Freedonia Group Inc
Published: Dec. 1, 2010 - 283 Pages
Table of Contents- INTRODUCTION
- I. EXECUTIVE SUMMARY
- II. MARKET ENVIRONMENT
- General
- Macroeconomic Outlook
- Demographic Trends
- Consumer Spending Outlook
- Physicians & Facility Trends
- Spa Industry Outlook
- Competitive Product Trends
- Medical Product Market Outlook
- Regulatory Issues
- International Activity
- III. COSMETIC PROCEDURES
- General
- Surgical
- Reshaping
- Implants
- Breast Implants
- Other Implants
- Lifts & Tucks
- Tummy Tucks
- Facelifts
- Breast Lifts
- Forehead Lifts
- Other Lifts
- Liposuction
- Other Surgical
- Nonsurgical
- Injections
- Botulinum Toxin
- Soft Tissue Fillers
- Other Injections
- Dermal Resurfacing
- Laser Treatments
- Laser Hair Removal
- Laser Dermal Resurfacing
- Other Laser Treatments
- Other Nonsurgical
- IV. PRODUCTS
- General
- Injectables
- Botulinum Toxin
- Soft Tissue Fillers
- Hyaluronic Acid
- Collagen
- Other Soft Tissue Fillers
- Other Injectables
- Equipment
- Lasers
- Hair Removal Lasers
- Dermal Resurfacing Lasers
- Other Lasers & Light-Based Systems
- Microdermabrators
- Liposuction Equipment
- Other Equipment
- Consumables
- Implants
- Breast Implants
- Other Implants
- Lip Implants
- Chin & Cheek Implants
- All Other Implants
- Wound Care Disposables
- Bandages & Dressings
- Wound Closures
- Other Wound Care Disposables
- Other Cosmetic Surgery Products
- V. RAW MATERIALS
- General
- Biological Materials
- Microbial Extracts
- Collagen
- Other Biological Materials
- Polymers
- Other Raw Materials
- VI. INDUSTRY STRUCTURE
- General
- Market Share
- Industry Restructuring
- Competitive Strategies
- Research & Development
- Cooperative Agreements
- Marketing
- Company Profiles
- Aesthera, see Solta Medical
- Alcon Incorporated
- Allergan Incorporated
- Alma Lasers Limited
- BioForm Medical, see Merz
- Candela, see Syneron Medical
- Covidien plc
- Cutera Incorporated
- Cynosure Incorporated
- Dectro International
- DermaMed USA Incorporated
- Diamond International Corporation Pty Limited
- Dynatronics Corporation
- Ethicon, see Johnson & Johnson
- ExcellaDerm Corporation
- Genesis Biosystems Incorporated
- Genzyme Corporation
- Hoya Corporation
- Implantech Associates Incorporated
- IRIDEX Corporation
- Johnson & Johnson
- Kendall, see Covidien
- Kinetic Concepts Incorporated
- LifeCell, see Kinetic Concepts
- Lumenis Limited
- Med-Aesthetic Solutions Incorporated
- Medicis Pharmaceutical Corporation
- Mentor Worldwide, see Johnson & Johnson
- Merz GmbH & Company KGaA
- Palomar Medical Technologies Incorporated
- Q-Med AB
- Sanofi-Aventis
- Smith & Nephew plc
- Solstice Neurosciences Incorporated
- Solta Medical Incorporated
- Suneva Medical Incorporated
- Syneron Medical Limited
- Syneture, see Covidien
- 3M Company
- Other Companies Mentioned in Study
- LIST OF TABLES
- SECTION I -- EXECUTIVE SUMMARY
- Summary Table
- SECTION II -- MARKET ENVIRONMENT
- 1 Macroeconomic Indicators
- 2 Population & Households
- 3 Personal Consumption Expenditures
- 4 Physicians & Facilities
- 5 Spa Facilities by Type
- 6 Medical Product & Equipment Demand
- SECTION III -- COSMETIC PROCEDURES
- 1 Cosmetic Procedures Demand by Type
- 2 Surgical Cosmetic Procedures Demand by Type
- 3 Cosmetic Reshaping Procedures Demand by Type
- 4 Cosmetic Implant Procedures Demand by Type
- 5 Cosmetic Lift & Tuck Procedures Demand by Type
- 6 Liposuction Procedures Demand by Type
- 7 Other Surgical Cosmetic Procedures Demand by Type
- 8 Nonsurgical Cosmetic Procedures Demand by Type
- 9 Cosmetic Injections Demand by Type
- 10 Cosmetic Botulinum Toxin Injections Demand
- 11 Cosmetic Soft Tissue Filler Injections Demand by Type
- 12 Other Cosmetic Injections Demand by Type
- 13 Cosmetic Dermal Resurfacing Treatment Demand by Type
- 14 Cosmetic Laser Treatment Demand by Type
- 15 Other Nonsurgical Cosmetic Procedures Demand
- SECTION IV -- PRODUCTS
- 1 Cosmetic Surgery Product Demand by Type
- 2 Cosmetic Injectables Demand by Type
- 3 Cosmetic Botulinum Toxin Demand by Formulation
- 4 Cosmetic Soft Tissue Filler Demand by Type
- 5 Cosmetic Hyaluronic Acid Filler Demand by Formulation
- 6 Cosmetic Collagen Filler Demand by Formulation
- 7 Other Cosmetic Soft Tissue Filler Demand by Type
- 8 Other Cosmetic Injectables Demand by Type
- 9 Cosmetic Surgery Equipment Demand by Type
- 10 Cosmetic Laser Demand by Procedure
- 11 Microdermabrator Demand
- 12 Liposuction Equipment Demand
- 13 Other Cosmetic Surgery Equipment Demand by Type
- 14 Cosmetic Surgery Consumables Demand
- 15 Cosmetic Implant Demand by Type
- 16 Cosmetic Breast Implant Demand by Type
- 17 Other Cosmetic Implant Demand by Type
- 18 Wound Care Disposables Demand in Cosmetic Surgery by Type
- 19 Bandages & Dressings Demand in Cosmetic Surgery
- 20 Wound Closures Demand in Cosmetic Surgery by Type
- 21 Other Wound Care Disposables Demand in Cosmetic Surgery
- 22 Other Cosmetic Surgery Product Demand
- SECTION V -- RAW MATERIALS
- 1 Raw Materials Demand in Cosmetic Surgery Products by Type
- 2 Biological Materials Demand in Cosmetic Surgery Products
- 3 Polymers Demand in Cosmetic Surgery Products
- 4 Other Raw Materials Demand in Cosmetic Surgery Products
- SECTION VI -- INDUSTRY STRUCTURE
- 1 US Cosmetic Surgery Product Sales by Company, 2009
- 2 Selected Acquisitions & Divestitures
- 3 Selected Cooperative Agreements
- LIST OF CHARTS
- SECTION II -- MARKET ENVIRONMENT
- 1 World Cosmetic Surgery Product Demand, 2009
- SECTION III -- COSMETIC PROCEDURES
- 1 Cosmetic Procedures Demand by Type, 1999-2019
- 2 Surgical Cosmetic Procedures Demand by Type, 2009
- 3 Nonsurgical Cosmetic Procedures Demand by Type, 1999-2019
- 4 Cosmetic Soft Tissue Filler Injections Demand by Type, 1999-2019
- SECTION IV -- PRODUCTS
- 1 Cosmetic Surgery Product Demand by Type, 1999-2019
- SECTION VI -- INDUSTRY STRUCTURE
- 1 US Cosmetic Surgery Product Market Share by Company, 2009
AbstractUS demand to grow 6.5% annually through 2014 Demand for products used in cosmeticsurgery is forecast to increase 6.5 percentper year to $2.8 billion in 2014, when16.1 million cosmetic procedures areexpected to be performed. The economicrecession that began in December 2007impacted the cosmetic surgery industrymost profoundly in surgical procedures,which suffered large drops in 2008 and2009. Likewise, demand for equipmentused to perform these surgeries fell moresharply than did that for less expensive,non-invasive nonsurgical procedures.Busy lifestyles and pervasive unemploymentrates have led to rapid increases indemand for minimally invasive procedures(such as injections and laser-basedprocedures). Minimally or non-invasiveprocedures will continue to take marketshare from invasive surgeries, althoughhealthy growth will remain in some areas,such as implants, where there are nonotable alternatives.
Lasers, other light-based equipment to remain largest, fastest-growing Equipment has traditionally held thelargest share of the cosmetic surgeryproduct market, and in 2009 accountedfor over one-third of demand. Purchasesof equipment were slowed by therecession and should see a strongrebound. Lasers and other light-basedsystems will continue to be the largestsector of equipment demand, and will seethe fastest growth going forward as newlaser-based treatments such as noninvasiveliposuction enter the market.
Injectables and implants fastest-growing products Through 2014, injectables and implantswill continue to be the two fastestgrowingproduct segments. Growth indemand for injectables has boomed sincethe 1990s when BOTOX (Allergan) firstentered the market. Cosmetic injectionsbenefit from increasing societal acceptanceas well as high consumer awarenessof their ability to provide a quick, noninvasivereduction in wrinkles with norecovery time. With 2009 and 2010market approvals of competing botulinumtoxin-based injectables, BOTOX isseeing its first direct competition, whichis expected to have significant impact onthe market. Development of newergenerationsoft tissue fillers will alsocontinue, with this segment expected tosee the fastest gains among injectables.Implants will continue to benefit fromsilicone’s market re-entry in 2006, asbreast implants -- the most commonaesthetic surgical procedure -- remainfast-growing. Next-generation implantmaterials (so-called “gummy bear”implants) are forecast to enter the marketonce they receive FDA approval followingclinical testing. These higher-valueimplants will drive further value gains.
Please Note: Freedonia requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
Get full details about this report >>
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports,
company profiles and country profiles from over 720 research firms. Our reports will
provide you with the critical business and competitive intelligence you need for strategic planning and marketing
research. Coverage includes the US, UK, Europe, Asia and global markets.
|